Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,225	5,280	3,348	2,186	2,097	3,039
Market Cap Growth	362.13%	57.69%	53.13%	4.24%	-30.98%	119.78%
Enterprise Value	7,661	4,739	2,933	1,787	1,603	2,598
Last Close Price	77.56	50.39	32.48	20.31	19.80	26.16
PE Ratio	67.89	37.78	31.74	21.59	18.64	28.67
Forward PE	54.43	32.11	32.61	19.95	21.01	32.91
PS Ratio	11.72	7.82	6.94	5.44	5.73	8.59
PB Ratio	12.03	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	12.04	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	46.43	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	45.84	26.66	26.36	18.17	12.49	20.00
PEG Ratio	-	-	-	-	1.50	-
EV/Sales Ratio	11.18	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	68.81	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	69.41	34.60	27.34	15.87	12.88	20.26
EV/FCF Ratio	43.24	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0	0.00	0.00	0.01
Debt / EBITDA Ratio	0.06	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.91	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.04	1.08	0.94	0.97	1.07	1.08
Quick Ratio	2.69	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.07	3.35	4.39	6.89	5.61	10.07
Return on Equity (ROE)	21.77%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	9.18%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	11.14%	14.34%	13.28%	16.01%	17.25%	17.79%
Return on Capital Employed (ROCE)	15.70%	19.60%	20.80%	22.00%	33.10%	24.50%
Earnings Yield	1.61%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	2.15%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-5.07%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q